Golden
Codagenix

Codagenix

Biotechnology company developing live attenuated vaccines

Codagenix is a privately held, biotechnology company based in Stony Brook, New York. The company focuses on constructing live-attenuated viral vaccines against multiple targets using the company's proprietary technology platform, SAVE. Standing for Synthetic Attenuated Virus Engineering, the platform relies on synthetic biology and the rational 're-design' of a target virus' entire genome to yield a vaccine strain. The customization process uses software-based algorithms to 're-code' the genome of a target virus.

The company's product pipeline includes vaccines for influenza, respiratory syncytial virus (RSV), dengue, foot and mouth disease virus (FMDV), pathogenic E. Coli, and other targets.

Timeline

People

Name
Role
Related Golden topics

Eckard Wimmer

Co-Founder, Senior Scientific Officer

J. Robert Coleman

Co-Founder & COO

Rishab Kaul

Employee

Steffen Mueller

Co-Founder, President, and Chief Scientific Officer

Further reading

Title
Author
Link
Type

Xconomy: With $2M, Codagenix Becomes Accelerate LI's First VC-Backed Grad

Web

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

References